Purple Biotech (PPBT) Research & Development (2014 - 2026)
Purple Biotech (PPBT) reported Research & Development of $1.2 million for Q1 2026, up 61.84% year-over-year from $760000.0 in Q1 2025, and up 61.84% on a QoQ basis from $760000.0 in Q1 2025.
Purple Biotech (PPBT) has 2 years of Research & Development data on file, last reported at $1.2 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -2.30 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.54 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - | 1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 587,000.00 |
| Jun 30, 2025 | 553,000.00 |
| Mar 31, 2025 | 760,000.00 |
| Dec 31, 2024 | 458,000.00 |
| Sep 30, 2024 | 1.35 Mn |
| Jun 30, 2024 | 2.39 Mn |
| Mar 31, 2024 | 3.42 Mn |
| Dec 31, 2023 | 5.24 Mn |
| Sep 30, 2023 | 4.59 Mn |
| Jun 30, 2023 | 3.71 Mn |
| Mar 31, 2023 | 3.50 Mn |
| Dec 31, 2022 | 4.82 Mn |
| Sep 30, 2022 | 3.47 Mn |
| Jun 30, 2022 | 2.08 Mn |
| Mar 31, 2022 | 5.95 Mn |
| Dec 31, 2021 | 3.25 Mn |
| Sep 30, 2021 | 1.62 Mn |
| Jun 30, 2021 | 2.09 Mn |
| Mar 31, 2021 | 4.87 Mn |
| Dec 31, 2020 | 4.32 Mn |
| Dec 31, 2019 | 986,000.00 |
| Dec 31, 2018 | 2.43 Mn |
| Dec 31, 2017 | 2.12 Mn |
| Dec 31, 2015 | 735,000.00 |
| Sep 30, 2015 | 906,000.00 |
| Dec 31, 2014 | 536,000.00 |
| Sep 30, 2014 | 728,000.00 |